NCT03729778View on ClinicalTrials.gov

Impact of HIV-1 and Aging on Mucosal Vaccine Responses

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 18, 2017

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2028

Conditions
HIV-1-infectionHuman Immunodeficiency VirusHIV/AIDSHIV Infections
Interventions
BIOLOGICAL

Prevnar-13

One time administration of prevnar-13 vaccine

Trial Locations (1)

80045

Rocky Mountain Regional VA Medical Center, Aurora

All Listed Sponsors
lead

VA Eastern Colorado Health Care System

FED